Ligand Pharmaceuticals
$107.699876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$107.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$2.30 (-2.09%) As of 1:11 PM EST today
-$2.30 (-2.09%) Today
Why Robinhood?
You can buy or sell LGND and other stocks, options, ETFs, and crypto commission-free!
About LGND
Ligand Pharmaceuticals Incorporated Common Stock, also called Ligand Pharmaceuticals, is a biopharmaceutical company, which engages in developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. Read More The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.
Employees
116
Headquarters
San Diego, California
Founded
1987
Market Cap
2.09B
Price-Earnings Ratio
3.96
Dividend Yield
0.00
Average Volume
438.22K
High Today
$111.24
Low Today
$106.94
Open Price
$109.58
Volume
180.79K
52 Week High
$166.52
52 Week Low
$84.45
Collections
Analyst Ratings
100%
of 6 ratings
Buy
100%
Hold
0%
Sell
0%
LGND Earnings
$0.49
$1.19
$1.89
$2.59
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
$0.61 per share
Actual
$0.49 per share